FSA Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61K | Hold |
8
| – | – | ﹤0.01% | 448 |
|
|
2025
Q1 | $2.16K | Hold |
8
| – | – | ﹤0.01% | 434 |
|
|
2024
Q4 | $1.88K | Hold |
8
| – | – | ﹤0.01% | 492 |
|
|
2024
Q3 | $2.2K | Buy |
+8
| New | +$2.2K | ﹤0.01% | 484 |
|
|
2024
Q1 | $1.2K | Hold |
8
| – | – | ﹤0.01% | 570 |
|
|
2023
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 516 |
|